Prognostic significance of eight immune-related genes on survival in patients with lung squamous cell carcinoma
- 1 March 2021
- journal article
- research article
- Published by Future Medicine Ltd in Biomarkers in Medicine
- Vol. 15 (4), 295-306
- https://doi.org/10.2217/bmm-2020-0483
Abstract
Aim: To build a valid prognostic model based on immune-related genes for lung squamous cell carcinoma (LUSC). Materials & methods: Differential expression of immune-related genes between LUSC and normal specimens from TCGA dataset and underlying molecular mechanisms were systematically analyzed. Constructing and validating the high-risk and low-risk groups for LUSC survival. Results: The immune-related gene-based prognostic index (IRGPI) could predict the overall survival in patients with different clinicopathological characteristics. Functional enrichment analysis of differential expression of immune-related gene signature indicated distinctive molecular pathways between high-risk and low-risk groups. Conclusion: Analysis of IRGs in LUSC enable us to stratify patients into distinct risk groups, which may help to screen LUSC patients at risk and decision making on follow-up therapeutic intervention.Keywords
This publication has 34 references indexed in Scilit:
- Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2014
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- A High Number of CD8+ T Cells Infiltrated in NSCLC Tissues is Associated With a Favorable PrognosisApplied Immunohistochemistry & Molecular Morphology, 2010
- Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non–Small Cell Lung Cancer among WomenCancer Epidemiology, Biomarkers & Prevention, 2009
- Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and PrognosisOncology, 2006
- S100A5: a marker of recurrence in WHO grade I meningiomasNeuropathology and Applied Neurobiology, 2004
- Expression of Caspase-3 and c-myc in Non-Small Cell Lung CancerCancer Research and Treatment, 2004
- Clinical significance of caspase-3 expression in pathologic-stage I, nonsmall-cell lung cancerInternational Journal of Cancer, 2001
- Differentiation‐specific expression of a novel G protein‐coupled receptor from Burkitt's lymphomaEuropean Journal of Immunology, 1992